Pharmacovigilance Market By 2023 to 2033: Emerging Technologies and Innovations

 According to the latest analysis by Future Market Insights (FMI), the global pharmacovigilance market is set to experience substantial growth, with projections indicating a surge from USD 6.87 billion in 2023 to USD 23.31 billion by 2033. This impressive growth reflects a robust Compound Annual Growth Rate (CAGR) of 13% over the forecast period.

The expansion of the pharmacovigilance market is driven by several key factors, including increased emphasis on drug safety and regulatory compliance across the pharmaceutical industry, heightened awareness of the importance of monitoring adverse drug reactions (ADRs), and significant technological advancements in data processing and analysis.

Get Access to Sample Report Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-1107

Key Drivers of Market Growth:

  • Rising Prevalence of Chronic Diseases: The growing incidence of chronic conditions such as diabetes, cancer, and cardiovascular diseases is fueling the development of new pharmaceuticals, thereby driving the need for effective pharmacovigilance practices.
  • Growing Awareness of Adverse Drug Reactions: Increased awareness of ADRs and higher patient medication consumption are propelling the demand for advanced pharmacovigilance services.
  • Stringent Regulatory Frameworks: Strict regulations mandating comprehensive drug safety monitoring by pharmaceutical companies and regulatory bodies are further contributing to market expansion.

Regional Insights:

  • North America: Dominates the market with over 30% share in 2021, driven by major pharmaceutical and medical device players, and a significant focus on drug abuse and ADRs. The United States, as a global leader in pharmaceuticals, held a 30.9% share of the global market in 2022, benefiting from stringent regulations and a patient-centric approach to pharmacovigilance.
  • Europe: Shows potential for growth, with the UK leading due to an increase in clinical trials. Germany's adoption of advanced pharmacovigilance tools like AI and big data is enhancing its market presence.
  • Asia Pacific: Expected to witness the fastest CAGR during the forecast period, driven by the proliferation of outsourcing companies offering cost-effective solutions. Rapid growth in the pharmaceutical industries of China and India highlights the need for stringent pharmacovigilance measures.

Competitive Landscape:

Key players in the pharmacovigilance industry, including pharmaceutical companies, regulatory authorities, and specialized service providers, are actively working to monitor and assess drug safety. They invest in advanced technologies and data analytics to improve pharmacovigilance processes and maintain compliance with regulations.

Recent developments include:

  • Qinecsa Solutions Ltd.: Acquired Commonwealth Informatics, Inc. in December 2022, establishing a comprehensive vigilance platform that combines top-tier pharmacovigilance services with a powerful digital platform.
  • Italian Medicines Agency: Launched the National Pharmacovigilance Network (RNF) in June 2022, featuring an international standard format for adverse reaction data collection and enhanced report management capabilities.

Key Market Players:

  • Accenture Plc.
  • Bristol-Myers Squibb
  • Clinquest Group B.V.
  • Cognizant Technology Solutions
  • Covance Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc.
  • ICON Plc
  • iGATE Corporation
  • iMED Global Corporation
  • inVentiv Health Inc.

Market Segmentation:

  • By Phase of Drug Development: Preclinical Studies, Phase I, Phase II, Phase III, Phase IV
  • By Type of Methods: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining
  • By Service Type Provider: In-house Pharmacovigilance, Contract Outsourcing
  • By Geography: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa (MEA)

Comments

Post a Comment

Popular posts from this blog

Teleradiology Services Market Analysis And Demand With Forecast Overview To 2032

Image
 In 2022, it is expected that the Teleradiology Services Market would be worth around US$ 31,880.57 Million. By 2032, it is anticipated that the market for teleradiology services would reach US$5,598.3 Million. with a 19% CAGR growth forecast through 2032. The global Teleradiology Services Market is estimated to reach a market valuation of US$ 1,971.4 Million by the end of 2016 and register a CAGR of 21.0% over the forecast period (2016–2026). The growth of this market can be attributed to the favorable government initiatives regarding the adoption of teleradiology in order to provide early disease diagnosis. Besides, the application of modern-day technologies such as the adoption of cloud-based technologies, blockchain, and cryptocurrencies will lead to better efficiency and cost-effective solutions. Increasing Investments for the development of advanced solutions is augmenting the demand for the industry. Request Sample PDF Brochure: https://www.futuremarketinsights.com/reports/...
Read more

Non-Vascular Stents Market to 2032 – Global Analysis and Forecasts by Types, Technologies, Applications and End-User Verticals

Image
 The Non-Vascular Stents Market is expected to grow at a CAGR of  4.5%  over the forecast period. (2022 - 2032). The sector is expected to be valued at  US$ 1.21 billion  in 2022 and  US$ 1.9 billion by 2032. The global non-vascular stents market is expected to move forward in response to the growing demand for minimally-invasive procedures. Rising technological and material advancements are assisting in the development of specially designed stents for use in a variety of indications thereby fueling the overall non-vascular stents market growth. Non-vascular stents use small, precise incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient's safety in jeopardy. The above-mentioned feature is anticipated to provide impetus to the non-vascular stents market adoption trends in coming years. Such a surgery is associated with a faster recovery period, resulting in a shorter hospital ...
Read more

From X-rays to AI: Veterinary Imaging Innovations of the Next Decade By 2022 to 2030

Image
  Between 2022 and 2030, the global veterinary imaging industry is expected to grow at a CAGR of 6.6%, from US$ 2.02 billion in 2022 to US$ 3.37 billion by 2030. A study by Future Industry Insights (FMI) predicted that by 2030, the worldwide veterinary imaging industry would bring in US$ 3.37 billion. The research study looks at the market development for veterinary imaging through 2030 in more than 20 nations. The report offers precise insights into some of the key players in the industry's crucial business strategies. According to the poll, investments are being made in the veterinary diagnostics industry as the trend towards pet humanization picks up speed. Additionally likely to fuel industry growth are governmental rules and a greater emphasis on preserving animal health. Request A Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-12368 Growth will also be fueled by the expansion of the animal and pet care industry as a w...
Read more